InnoCare Pharma (688428.SH) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec18

Nocia Healthcare's Aubitini IIb Clinical Trial for Systemic Lupus Erythematosus Achieves Primary Endpoint

07:12

Dec15

Novocres Advances Orelabrutinib into Phase III Clinical Trials

03:08

Dec14

Nocile's Aubitini Reaches Primary Endpoint in Phase IIb Clinical Trial for Systemic Lupus Erythematosus, Approved for Phase III Registration Clinical Trial

08:17

Dec11

Novartis Joins Genentech in Securing Approval for Next-Generation TRK Inhibitor Zoratet 骖 bine

10:16

Dec10

Nocaijianghai Displays Multiple Research Results of BTK Inhibitor Orelabrutinib

01:23

Nov28

Nocigna Completes First Patient Dosing for Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib

00:34

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 383.89 M, Net Income -34.32 M, EPS -0.0188

Aug19

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 350.17 M, Net Income -48.06 M, EPS -0.0396

May13

Earning Release(CST)

FY2025 Q1 Earning Release (CNY) Revenue 381.26 M, Net Income 17.97 M, EPS 0.01

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More